Medopren en es it fr

Medopren Brand names, Medopren Analogs

Medopren Brand Names Mixture

  • No information avaliable

Medopren Chemical_Formula


Medopren RX_link

Medopren fda sheet

Medopren FDA

Medopren msds (material safety sheet)

Medopren MSDS

Medopren Synthesis Reference

No information avaliable

Medopren Molecular Weight

1270.28 g/mol

Medopren Melting Point

No information avaliable

Medopren H2O Solubility

Freely soluble as sodium salt (> 200mg/mL)

Medopren State


Medopren LogP

No information avaliable

Medopren Dosage Forms

Powder for solution (for injection)

Medopren Indication

For use in the treatment of patients with esophageal candidiasis and prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation.

Medopren Pharmacology

Formerly known as FK463, micafungin is a novel antifungal agent. It is a glucan synthesis inhibitor of the echinocandin structural class. The U.S. Food and Drug Administration approved micafungin in March 2005. Micafungin inhibits an enzyme essential for fungal cell-wall synthesis and is fungicidal (lethal) for Candida. Micafungin can be used concomitantly with a variety of other drugs, including the HIV protease inhibitor ritonavir and the transplant medications cyclosporine and tacrolimus.

Medopren Absorption

No information avaliable

Medopren side effects and Toxicity

Intravenous LD50 in rats is 125mg/kg. In dogs it is >200mg/kg. No cases of overdosage have been reported. Repeated daily doses up to 8 mg/kg (maximum total dose of 896 mg) in adult patients have been administered in clinical trials with no reported dose-limiting toxicity. The minimum lethal dose is 125 mg/kg in rats, equivalent to 8.1 times the recommended human clinical dose for esophageal candidiasis based on body surface area comparisons.

Medopren Patient Information

No information avaliable

Medopren Organisms Affected

Aspergillis, Candida and other fungi